IN2013MU01510A - - Google Patents

Info

Publication number
IN2013MU01510A
IN2013MU01510A IN1510MU2013A IN2013MU01510A IN 2013MU01510 A IN2013MU01510 A IN 2013MU01510A IN 1510MU2013 A IN1510MU2013 A IN 1510MU2013A IN 2013MU01510 A IN2013MU01510 A IN 2013MU01510A
Authority
IN
India
Prior art keywords
relates
bendamustine
treatment
nitrogen
disease states
Prior art date
Application number
Other languages
English (en)
Inventor
Rajesh Jain
Sing Sarabjith
Vipul Bhatt Sivagami
Dhanvantrao Shinde Dinesh
Original Assignee
Panacea Biotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Ltd filed Critical Panacea Biotec Ltd
Priority to IN1510MU2013 priority Critical patent/IN2013MU01510A/en
Publication of IN2013MU01510A publication Critical patent/IN2013MU01510A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
IN1510MU2013 2013-04-25 2013-04-25 IN2013MU01510A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN1510MU2013 IN2013MU01510A (es) 2013-04-25 2013-04-25

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1510MU2013 IN2013MU01510A (es) 2013-04-25 2013-04-25

Publications (1)

Publication Number Publication Date
IN2013MU01510A true IN2013MU01510A (es) 2015-04-17

Family

ID=54394694

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1510MU2013 IN2013MU01510A (es) 2013-04-25 2013-04-25

Country Status (1)

Country Link
IN (1) IN2013MU01510A (es)

Similar Documents

Publication Publication Date Title
JOP20200192A1 (ar) أجسام مضادة لـ tigit
TW201613901A (en) New compounds
UA116648C2 (uk) Фумарати як проліки та їх застосування при лікуванні різних захворювань
PH12016501122A1 (en) Delayed release compositions of linaclotide
NZ708727A (en) Conjugate compounds
CL2018000565A1 (es) Compuestos derivados de piridinona dicarboxamida, inhibidores de bromodominio; composicion farmaceutica; combinacion farmaceutica; utiles en el tratamiento de enfermedades autoinmunitarias, inflamatorias, virales y cancer, entre otras.
HN2012000023A (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
MX2017004473A (es) Formulaciones de betalactamasa y usos de las mismas.
EA201690513A1 (ru) Комбинация ингибитора mek и ингибитора erk для применения в лечении гиперпролиферативных заболеваний
MY186047A (en) Eutectic formulations of cyclobenzaprine hydrochloride
IN2013MU03583A (es)
TR201910866T4 (tr) Kanser tedavisi için birleşik preparasyonlar.
IN2014MN02236A (es)
MX2017012596A (es) Una composicion farmaceutica y el uso de la misma.
EA201591758A1 (ru) Подкожное введение adamts13
EA201591717A1 (ru) Твердые формы гидрохлорида вемурафениба
MX2022006770A (es) Dispersiones solidas de bendamustina e infusion continua.
TR201905218T4 (tr) Nörodejenerati̇f hastaliklarin tedavi̇si̇ i̇çi̇n yararli vi̇tanoli̇dler.
MX2017013879A (es) Composiciones que comprenden anakinra.
PH12017501979A1 (en) Pharmaceutical compound
WO2014170769A3 (en) Bendamustine lyophilized pharmaceutical compositions
IN2013MU01510A (es)
EA201791648A1 (ru) Комбинация гиалуроновой кислоты и макроголя и фармацевтические композиции, содержащие ее
WO2015003049A3 (en) Compositions and methods to treat inflammatory joint disease
IN2014KN02584A (es)